Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

KRX/033270 stock hub

KRX/033270 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

KRX/033270is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

284.7B

Korea Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

KRX/033270

In the news

Latest news · KRX/033270

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E6.9

P25 9.8P50 17.1P75 31.9

Trailing P/E15.8

P25 12P50 23.1P75 39.5

ROE12.2

P25 -17.1P50 0.7P75 8.5

ROIC12.1

P25 -9P50 1.3P75 6.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All KRX/033270 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

238

Groups with data

Currency

KRW

Showing 238 of 238 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Employees	665
Exchange	Korea Stock Exchange
Financial currency	KRW
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	KR7033270000
Last refreshed	2026-05-10
Market cap	KRW 284.7B
Price	KRW 19,920
Price currency	KRW
Rev Per Employee	242,762,632.71x
Sector	Healthcare
Sic	2834
Symbol	krx/033270
Website	https://www.kup.co.kr

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	7.03%
FCF yield	3.86%
Forward P/E	6.92x
P/B ratio	1.67x
P/E ratio	15.8x
P/S ratio	1.76x
PE Ratio10 Y	10.9x
PE Ratio3 Y	13.58x
PE Ratio5 Y	10.27x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	14.74%
EBITDA Margin	18.88%
FCF margin	6.81%
Gross margin	52.53%
Gross Profit	KRW 84.8B
Gross Profit Growth	10.91%
Gross Profit Growth Q	0.03%
Gross Profit Growth3 Y	2.78%
Gross Profit Growth5 Y	1.85%
Net Income	KRW 20B
Net Income Growth	20.99%
Net Income Growth Q	-7.11%
Net Income Growth Quarters	1%
Net Income Growth Years	1%
Net Income Growth3 Y	9.84%
Net Income Growth5 Y	9.5%
Pretax Margin	15.87%
Profit Margin	12.4%
Profit Per Employee	KRW 30.1M
Profitable Years	20
ROA	6.78
Roa5y	7.73
ROCE	12.23
ROE	12.21
Roe5y	14.72
ROIC	12.08
Roic5y	14.37

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	1.51%
Cagr15y	8.43%
Cagr1y	5.26%
Cagr20y	13.11%
Cagr3y	-2.53%
Cagr5y	-16.42%
Div CAGR10	9.33%
Div CAGR3	13.25%
Div CAGR5	10.52%
EPS Growth	24.33
EPS Growth Q	-5.79
EPS Growth Quarters	1
EPS Growth Years	1
EPS Growth3 Y	6.68
EPS Growth5 Y	8.85
FCF Growth	-4.61%
FCF Growth Q	-73.14%
FCF Growth3 Y	8.69%
FCF Growth5 Y	14.13%
OCF Growth	24.44%
OCF Growth Q	-24.51%
OCF Growth3 Y	2.58%
OCF Growth5 Y	11.04%
Revenue Growth	8x
Revenue Growth Q	6.1x
Revenue Growth Quarters	1x
Revenue Growth Years	5x
Revenue Growth3 Y	4.62x
Revenue Growth5 Y	5.2x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 0.74
Assets	KRW 223.9B
Cash	KRW 38.2B
Current Assets	KRW 110.2B
Current Liabilities	KRW 29.4B
Debt	KRW 23.6B
Debt EBITDA	KRW 0.78
Debt Equity	KRW 0.14
Debt FCF	KRW 2.15
Equity	KRW 170.7B
Interest Coverage	30.57
Liabilities	KRW 53.2B
Long Term Assets	KRW 113.7B
Long Term Liabilities	KRW 23.8B
Net Cash	KRW 14.6B
Net Cash By Market Cap	KRW 5.11
Net Cash Growth	230.84%
Net Debt EBITDA	KRW -0.48
Net Debt Equity	KRW -0.09
Net Debt FCF	KRW -1.33
Tangible Book Value	KRW 166.3B
Tangible Book Value Per Share	KRW 10,586
WACC	6.02

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.75
Inventory Turnover	2.64
Net Working Capital	KRW 49.1B
Quick ratio	2.82
Working Capital	KRW 80.8B
Working Capital Turnover	KRW 1.98

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	2.69%
Dividend Growth	35.56%
Dividend Growth Years	6%
Dividend per share	KRW 610
Dividend Years	25
Dividend Yield	3.06%
Ex Div Date	2025-12-29
Last Dividend	KRW 610
Payout Frequency	Annual
Payout Ratio	15.89%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	16.18%
1Y total return	5.26%
200-day SMA	19,878.1
3Y total return	-7.41%
50-day SMA	20,196.6
50-day SMA vs 200-day SMA	50over200
5Y total return	-59.21%
All Time High	112,000
All Time High Change	-82.21%
All Time High Date	2020-09-08
All Time Low	185.8
All Time Low Change	10,620.17%
All Time Low Date	2001-02-19
ATR	428.9
Beta	0.37
Beta1y	0.04
Beta2y	0.23
Ch YTD	4.46
High	19,940
High52	22,450
High52 Date	2025-07-17
High52ch	-11.27%
Low	19,760
Low52	18,080
Low52 Date	2026-01-21
Low52ch	10.18%
Ma50ch	-1.37%
Price vs 200-day SMA	0.21%
RSI	44.83
RSI Monthly	44.42
RSI Weekly	49.66
Sharpe ratio	0.04x
Sortino ratio	0.3
Total Return	5.75%
Tr YTD	4.46
Tr15y	236.51%
Tr1m	1.27%
Tr1w	-0.65%
Tr3m	5.01%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW 23.8B
Operating Income Growth	26.47
Operating Income Growth Q	-33.63
Operating Income Growth3 Y	4.77
Operating Income Growth5 Y	6.78
Operating margin	14.74

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	7,629,420%
Net Borrowing	-402,293,370
Shares Insiders	33.45%
Shares Institutions	4.6%
Shares Out	14,289,795
Shares Qo Q	-0.39%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW 11B
Average Volume	31,518.85x
Bv Per Share	10,866.8
CAPEX	KRW -14B
Ch10y	-0.15
Ch15y	170.2
Ch1m	1.27
Ch1w	-0.65
Ch1y	2.84
Ch20y	781.5
Ch3m	5.01
Ch3y	-13.2
Ch5y	-62.7
Ch6m	5.23
Change	0.35%
Change From Open	0.1
Close	19,850
Days Gap	0.25
Depreciation Amortization	6,677,896,810
Dollar Volume	604,791,120
Earnings Date	2026-05-14
EBIT	KRW 23.8B
EBITDA	KRW 30.5B
EPS	KRW 1,261
F Score	7
FCF	KRW 11B
FCF Per Share	KRW 769
Financing CF	-6,743,765,410
Fiscal Year End	December
Founded	1,987
Graham Number	17557.35969
Graham Upside	-11.86
Income Tax	KRW 5.5B
Investing CF	-30,576,229,190
Is Primary Listing	1
Last Earnings Date	2026-02-27
Last Report Date	2015-09-30
Last Split Date	2014-01-20
Last Split Type	Forward
Lynch Fair Value	KRW 11,979
Lynch Upside	-39.87
Ma150	19,581.5
Ma150ch	1.73%
Ma20	20,418.5
Ma20ch	-2.44%
Net CF	-11,763,312,000
Next Earnings Date	2026-05-14
Open	19,900
P FCF Ratio	25.91
P OCF Ratio	11.38
Payment Date	2026-04-13
Position In Range	88.89
Ppne	74,121,029,000
Price Date	2026-05-08
Price EBITDA	KRW 9.34
Ptbv Ratio	1.71
Relative Volume	0.98x
Revenue	161,437,150,750x
SBC By Revenue	0x
Share Based Comp	-20
Tax By Revenue	3.44x
Tax Rate	21.66%
Tr20y	1,075.66%
Tr6m	7.7%
Volume	30,361
Z Score	5.75

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

KRX/033270 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+3.1%

$610 annual per share

Payout ratio

+15.9%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+10.5%

6 consecutive years of growth

Total shareholder yield

+5.8%

Next ex-dividend date: 2025-12-29

Performance

KRX/033270 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns KRX/033270?

Insider, institutional, and short-interest positioning.

Institutional ownership

+4.6%

Share of float held by funds and institutions

Insider ownership

+33.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

KRX/033270 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

44.8

Neutral momentum band

Price vs 200-day MA

+0.2%

50/200-day relationship not available

Beta (5Y)

0.37

Less volatile than the market

Sharpe ratio

0.04

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About KRX/033270

Hub-level FAQ points readers to the deeper analysis pages.

What is the current krx/033270 stock rating?

krx/033270 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full krx/033270 analysis?

The full report lives at /stocks/krx/033270/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for krx/033270?

The latest report frames krx/033270 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the krx/033270 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.